BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Clean Air and Water (quality) CAW

Climate Change Benefits of Biofuels Department of Defense Applications of Advanced Biofuels

Contacted: Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Treasury, Dept of; SENATE; Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); White House Office

Science/Technology SCI

Small Business Innovation Research (SBIR) Program Implementation of Final RulemakingResearch & Development Tax Credit Extension Startup Innovation Credit (Senator Coons Discussion Draft) Innovative Research and Competitiveness Act (Senator Carper Discussion Draft)

Contacted: Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Treasury, Dept of; Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); SENATE

Homeland Security HOM

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 H.R. 307: Pandemic and All-Hazards Preparedness Reauthorization ActBiodefense Research, Development, and Procurement (Non-Funding Issues) H.R. 307: Pandemic and All-Hazards Preparedness Reauthorization Act

Contacted: U.S. Trade Representative (USTR); SENATE; Treasury, Dept of; White House Office; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP)

Bills named: H.R. 933 (113th), H.R. 307 (113th)

Trade (domestic/foreign) TRD

Livestock Cloning/Product Labeling Discussions with EU on Animal CloningWorld Trade Organization Special 301 Submissions Export Registrations for Products with Expired Patents Intellectual Property International Enforcement Compulsory Licensing Foreign Agricultural Biotechnology Laws and Regulations China Biotechnology Regulations Low-Level Presence Foreign Government Policies International Biotechnology Agreement Asynchrony of International Approvals EU Biotechnology Bilateral Discussions TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuitcalsl Regulatory Transparency Sanitary and Phytosanitary Issues U.S./European Union High-Level Dialogue on Regulatory Issues

Contacted: Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Treasury, Dept of; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); SENATE; White House Office; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Agriculture, Dept of (USDA)

Agriculture AGR

USDA/APHIS Agricultural Biotechnology Regulations Efficient Science-Based Reviews of Biotech ProductsLivestock Cloning/Product Labeling Discussions with EU on Animal Cloning EPA Regulations on Agricultural Biotechnology Genetically Engineered (GE) Animals FDA Approval Amendment to Restrict FDA Approval of GE Salmon Labeling Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 S. Con. Res. 8: Senate Budget Resolution Export Registrations for Products with Expired Patents Labeling of Genetically Engineered Crops Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Adventitious Presence (Low Level Presence) U.S. Low Level Presence Policy S. 10: Agriculture Reform, Food, and Jobs Act of 2013 S (Farm Bill) Foreign Agricultural Biotechnology Laws and Regulations Asynchrony of International Approvals China Biotechnology Regulations International Biotechnology Agreement EU Biotechnology Bilateral Discussions Low-Level Presence Foreign Government Policies Agricultural Biotechnology Regulatory Reform and Modernization S. 10: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Benefits of Ag-Biotech Research and Innovation Regulatory Review of Animal Pharmaceuticals S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 TransPacific Partnership Sanitary and Phytosanitary Issues

Contacted: Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Treasury, Dept of; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA)

Bills named: S. 10 (113th), H.R. 933 (113th), S. 622 (113th), S.Con.Res. 8 (113th)

Taxation/Internal Revenue Code TAX

Biofuels Production Tax Credit Extension Accelerated Depreciation ExtensionResearch & Development Tax Credit Extension Startup Innovation Credit (Senator Coons Discussion Draft) Innovative Research and Competitiveness Act (Senator Carper Discussion Draft) Capital Formation Investment Incentives High Technology Small Business Research Incentives Act (Discussion Draft) Vaccine Access/Financing Tax for Seasonal Influenza Funding H.R. 425/S.391: A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Tax Reform Renewable Chemicals/Bio-based Products New Production Tax Credit for Renewable Chemicals Expansion of Advanced Manufacturing Investment Tax Credit to Renewable Chemicals and Bio-Based Products Expansion of Master Limited Partnerships to Renewable Chemicals

Contacted: Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); White House Office; U.S. Trade Representative (USTR); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); SENATE

Bills named: H.R. 425 (113th), S. 391 (113th)

Copyright/Patent/Trademark CPT

Patent Reform LitigationTransPacific Partnership Data and Intellectual Property Protection for Pharmaceuitcalsl World Trade Organization Special 301 Submissions Generic Drug Patent Settlements S. Con. Res. 8: Senate Budget Resolution Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization DNA Patenting and Licensing Intellectual Property International Enforcement Compulsory Licensing International Patent Law Harmonization Patent Exhaustion

Contacted: Environmental Protection Agency (EPA); Treasury, Dept of; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); White House Office; Office of Management & Budget (OMB); SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP)

Bills named: S.Con.Res. 8 (113th)

Energy/Nuclear ENG

Biofuels Production Tax Credit Extension Accelerated Depreciation Extension Department of Defense Funding/Application of Advanced BiofuelsBiofuels Cont. H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 (Toomey Amendment) Renewable Fuel Standard Department of Defense Appropriations Act for FY 2014 Energy and Water Development and Related Agencies Appropriations Act for FY 2014 Biorefineries Reauthorization/Funding of Biorefinery Assistance Program DOE Biomass Program Department of Defense Funding S. 10: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 (Toomey Amendment) S. Con. Res. 8: Senate Budget Resolution Renewable Chemicals/Bio-based Products New Production Tax Credit for Renewable Chemicals Expansion of Advanced Manufacturing Investment Tax Credit to Renewable Chemicals and Bio-Based Products Expansion of Master Limited Partnerships to Renewable Chemicals Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products Reauthorization/Funding of USDA Bio-Preferred Program S. 10: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Biomass Programs Reauthorization/Funding of Biomass Crop Assistance Program Reauthorization/Funding of Biomass R&D Program S. 10: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013

Contacted: SENATE; Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Treasury, Dept of; HOUSE OF REPRESENTATIVES; White House Office; Agriculture, Dept of (USDA)

Bills named: H.R. 933 (113th), S. 10 (113th), S.Con.Res. 8 (113th)

Health Issues HCR

Funding for National Institutes of Health H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Vaccine Access/Financing Tax for Seasonal Influenza Funding H.R. 425/S. 391: A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Adult Immunization Policies Adult Immunization Senate Discussion Draft 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Drug Safety and Review Implementation of S. 3187: The Food and Drug Administration Safety and Innovation Act Regulatory Reforms for Innovative Products Expedited Approval Pathways E-Pedigree and Anti-Counterfeiting Supply Chain Integrity Pharmacy Compounding Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development, and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 H.R. 307: Pandemic and All-Hazards Preparedness Reauthorization Act Cures Acceleration Network Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biodefense Research, Development, and Procurement (Non-Funding Issues) H.R. 307: Pandemic and All-Hazards Preparedness Reauthorization Act Reimbursement for Innovative Products Medicare Part D Prescription Drug Program Medicare Part B Physician-Administered Products H.Con.Res. 25: House Budget Resolution (Democratic Caucus Substitute) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 U.S./European Union High-Level Dialogue on Regulatory IssuesSequestration of PDUFA Fees H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Implementation of S. 365: Budget Control Act TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuitcalsl Regulatory Transparency

Contacted: Treasury, Dept of; SENATE; Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); White House Office; Office of Management & Budget (OMB); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO)

Bills named: S. 365 (113th), H.R. 307 (113th), H.R. 425 (113th), S. 3187 (113th), H.R. 3590 (113th), H.R. 933 (113th), S. 391 (113th), H.Con.Res. 25 (113th)

Small Business SMB

Sarbanes Oxley Section 404 (b) Mandatory Audit Firm Rotation (Rep. Hurt Discussion Draft) Tax ReformCapital Formation Investment Incentives High Technology Small Business Research Incentives Act (Discussion Draft) Expansion of Exemption Under SEC Regulation A H.R. 701: To amend a provision of the Securities Act of 1933 directing the Securities and Exchange Commission to add a particular class of securities to those exempted under such Act to provide a eadline for such action Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions Small Business Innovation Research (SBIR) Program Implementation of Final Rulemaking

Contacted: HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); White House Office; Treasury, Dept of; Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Food & Drug Administration (FDA)

Bills named: H.R. 701 (113th)

Medicare/Medicaid MMM

Reimbursement for Innovative Products Medicare Part D Prescription Drug ProgramReimbursement for Innovative Products Cont. Medicare Part B Physician-Administered Products H.Con.Res. 25: House Budget Resolution (Democratic Caucus Substitute) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013

Contacted: Treasury, Dept of; SENATE; Environmental Protection Agency (EPA); White House Office; Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS)

Bills named: H.Con.Res. 25 (113th), H.R. 933 (113th)

Budget/Appropriations BUD

Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development, and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 H.R. 307: Pandemic and All-Hazards Preparedness Reauthorization Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Funding for Renewable Chemicals/Bio-based Products Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products Reauthorization/Funding of USDA Bio-Preferred Program S.10: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Funding for Biofuels Department of Defense Funding/Application of Advanced Biofuels Department of Defense Appropriations Act for FY 2014 Department of Energy and Water and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 (Toomey Amendment) Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Cures Acceleration Network Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Funding for Biomass Programs H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Reauthorization/Funding of Biomass Crop Assistance Program Reauthorization/Funding of Biomass R&D Program S. 10: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) Reimbursement for Innovative Products Medicare Part D Prescription Drug Program Medicare Part B Physician-Administered Products H.Con.Res. 25: House Budget Resolution (Democratic Caucus Substitute) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013Funding for Biorefineries Reauthorization/Funding of Biorefinery Assistance Program DOE Biomass Program Department of Defense Funding S. 10: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 (Toomey Amendment) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 S. Con. Res. 8: Senate Budget Resolution

Contacted: Office of Management & Budget (OMB); White House Office; Agriculture, Dept of (USDA); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Treasury, Dept of; Patent & Trademark Office (PTO)

Bills named: S. 10 (113th), S.Con.Res. 8 (113th), H.R. 933 (113th), H.R. 307 (113th), S. 365 (113th), H.Con.Res. 25 (113th)

Consumer Issues/Safety/Products CSP

Livestock Cloning/Project Labeling Discussions with EU on Animal CloningUSDA/APHIS Agricultural Biotechnology Regulations Efficient Science-Based Reviews of Biotech Products Genetically Engineered (GE) Animals FDA Approval Labeling Amendment to Restrict FDA Approval of GE Salmon Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 S. Con. Res. 8: Senate Budget Resolution Generic Drug Patent Settlements S. Con. Res. 8: Senate Budget Resolution Labeling of Genetically Engineered Crops Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Drug Safety and Review Implementation of S. 3187: The Food and Drug Administration Safety and Innovation Act Regulatory Reforms for Innovative Products Expedited Approval Pathways E-Pedigree and Anti-Counterfeiting Supply Chain Integrity Pharmacy Compounding Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013

Contacted: Environmental Protection Agency (EPA); White House Office; SENATE; Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Treasury, Dept of; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 933 (113th), S. 3187 (113th), S. 622 (113th), S.Con.Res. 8 (113th)

Food Industry (safety, labeling, etc.) FOO

Livestock Cloning/Project Labeling Discussions with EU on Animal CloningGenetically Engineered (GE) Animals FDA Approval Labeling Amendment to Restrict FDA Approval of GE Salmon Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 S. Con. Res. 8: Senate Budget Resolution Labeling of Genetically Engineered Crops Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013

Contacted: Office of Management & Budget (OMB); Natl Institutes of Health (NIH); Treasury, Dept of; Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); White House Office; Food & Drug Administration (FDA); SENATE

Bills named: S.Con.Res. 8 (113th), H.R. 933 (113th), S. 622 (113th)

Animals ANI

Livestock Cloning/Product Labeling Discussions with EU on Animal CloningGenetically Engineered (GE) Animals Labeling FDA Approval Amendment to Restrict FDA Approval of GE Salmon Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 S. Con. Res. 8: Senate Budget Resolution Regulatory Review of Animal Pharmaceuticals S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013

Contacted: Office of Science & Technology Policy (OSTP); SENATE; Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Treasury, Dept of; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH)

Bills named: H.R. 933 (113th), S. 622 (113th), S.Con.Res. 8 (113th)

Fuel/Gas/Oil FUE

Biofuels Production Tax Credit Extension Accelerated Depreciation Extension Department of Defense Funding/Application of Advanced BiofuelsBiofuels Cont. H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 (Toomey Amendment) Renewable Fuel Standard Department of Defense Appropriations Act for FY 2014 Energy and Water Development and Related Agencies Appropriations Act for FY 2014 Biorefineries Reauthorization/Funding of Biorefinery Assistance Program DOE Biomass Program Department of Defense Funding S. 10: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 (Toomey Amendment) S. Con. Res. 8: Senate Budget Resolution Renewable Chemicals/Bio-based Products New Production Tax Credit for Renewable Chemicals Expansion of Advanced Manufacturing Investment Tax Credit to Renewable Chemicals and Bio-Based Products Expansion of Master Limited Partnerships to Renewable Chemicals Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products Reauthorization/Funding of USDA Bio-Preferred Program S. 10: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Biomass Programs Reauthorization/Funding of Biomass Crop Assistance Program Reauthorization/Funding of Biomass R&D Program S. 10: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013

Contacted: Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); SENATE; White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Treasury, Dept of; Office of Science & Technology Policy (OSTP)

Bills named: S. 10 (113th), H.R. 933 (113th), S.Con.Res. 8 (113th)

Medical/Disease Research/Clinical Labs MED

Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 H.R. 307: Pandemic and All-Hazards Preparedness Reauthorization Act Cures Acceleration Network Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biodefense Research, Development, and Procurement (Non-Funding Issues) H.R. 307: Pandemic and All-Hazards Preparedness Reauthorization Act

Contacted: White House Office; Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Treasury, Dept of; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); SENATE; Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO)

Bills named: H.R. 3590 (113th), H.R. 307 (113th), H.R. 933 (113th)